iRadimed Reduces Full-Year Guidance Amid Production Constraints

iRadimed Corporation lowered its full-year guidance because quality-related constraints slowed its production ramp-up. Demand for its four-channel 3870 infusion pump remains strong, supporting bookings and backlog as existing and new customers replace legacy devices. The article did not provide specific financial figures or report a stock-price movement.